| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/22/2005 | EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | EP1542716A1 Growth hormone releasing peptides |
| 06/22/2005 | EP1542691A2 Composition for the treatment of nasopharyngeal carcinoma and use thereof |
| 06/22/2005 | EP1542685A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542684A2 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542674A1 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 06/22/2005 | EP1542669A1 Leucine-enriched nutritional compositions |
| 06/22/2005 | EP1542667A2 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/22/2005 | EP1542609A2 Methods for up-regulating antigen expression in tumors |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1414299A4 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 06/22/2005 | EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/22/2005 | EP1373243B1 Aminoflavone compounds, compositions, and use thereof |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1350794B1 Process for preparing substance gm-95 |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1263749B1 Taxane anticancer agents |
| 06/22/2005 | EP1191025B1 Crystals of lansoprazole |
| 06/22/2005 | EP1173160B1 (e)-styryl sulfone anticancer agents |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | EP1073465B1 T cell inhibitory receptor compositions and uses thereof |
| 06/22/2005 | EP1040111B1 Integrin receptor antagonists |
| 06/22/2005 | EP1007533B1 Bioconjugates and delivery of bioactive agents |
| 06/22/2005 | EP0973554B1 Chelating agents |
| 06/22/2005 | CN1630819A Renal cell carcinoma markers |
| 06/22/2005 | CN1630730A Methods for detecting and treating the early onset of aging-related conditions |
| 06/22/2005 | CN1630724A Compositions and methods for inhibiting expression of a target gene |
| 06/22/2005 | CN1630716A Hematopoietic cells from human embryonic stem cells |
| 06/22/2005 | CN1630714A Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 06/22/2005 | CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 06/22/2005 | CN1630658A Variolin derivatives as anti-cancer agents |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630650A Nitrogenous heterocyclic compound and medicine thereof |
| 06/22/2005 | CN1630649A Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/22/2005 | CN1630648A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |
| 06/22/2005 | CN1630641A Farnesyl protein transferase inhibitors as antitumor agents |
| 06/22/2005 | CN1630638A Aryl ureas as kinase inhibitors |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1630534A Methods and compositions for treating hyperproliferative conditions |
| 06/22/2005 | CN1630531A Composition comprising immunogenic microparticles |
| 06/22/2005 | CN1630529A B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 06/22/2005 | CN1630524A 非肠道顺铂乳剂 Cisplatin parenteral emulsion |
| 06/22/2005 | CN1630519A Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
| 06/22/2005 | CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1629285A Natural killer cell for transgenic expression cell chemotactic factors |
| 06/22/2005 | CN1629283A Epothilone -a microtubule stabilizer for treating tumor and blood vessel restenosis |
| 06/22/2005 | CN1629186A Ganoderma lucidum polysaccharide protein and its preparing method and use |
| 06/22/2005 | CN1629182A Oslasodine hydrochloride preparing process |
| 06/22/2005 | CN1629177A (trans)-2-deoxy-2-(fluoromethano)-4-R acyl-cytidine compound, preparation process and use thereof |
| 06/22/2005 | CN1629173A Novel antibiotic preparing process |
| 06/22/2005 | CN1629171A Novel sunplatinum preparation and its preparation process |
| 06/22/2005 | CN1629165A Lanthanum amino acid complex and its preparing process and application |
| 06/22/2005 | CN1629155A Pyrimidinyl carboxylic acid amide compounds with anti-tumor activity and salts thereof |
| 06/22/2005 | CN1629150A Paclitaxol predrug of biodegradable polymer and its synthesis method |
| 06/22/2005 | CN1629145A Condensed heteroaryl derivatives |
| 06/22/2005 | CN1629139A Dialkyl and diaryl tetrasubstituted heterocyclic compounds, preparing process and use thereof |
| 06/22/2005 | CN1628859A 杂交酵母癌症疫苗 Hybrid yeast cancer vaccine |
| 06/22/2005 | CN1628853A Anti-cancer medicine composition |
| 06/22/2005 | CN1628852A Anti solid tumor medicine composition |
| 06/22/2005 | CN1628851A Anti-cancer medicine composition |
| 06/22/2005 | CN1628850A Anti solid tumor medicine composition |
| 06/22/2005 | CN1628849A Anti-cancer medicine composition |
| 06/22/2005 | CN1628833A Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof |
| 06/22/2005 | CN1628828A Chinese medicine for preventing and resisting cancer |
| 06/22/2005 | CN1628826A Medicine for treating cancer |
| 06/22/2005 | CN1628825A Medicine for treating lung cancer and preparing process thereof |
| 06/22/2005 | CN1628824A Medicine for treating liver cancer |
| 06/22/2005 | CN1628823A Medicine for reinforcing primordial qi of late stage cancer patents |
| 06/22/2005 | CN1628818A Muskmelon pedicel and cricket containing pills for diuresis |
| 06/22/2005 | CN1628811A Drug plaster for preventing and treating tumor |
| 06/22/2005 | CN1628808A Chinese traditional medicine for treating acute leukemia |
| 06/22/2005 | CN1628801A Chinese medicinal powder for treating esophagus cancer |
| 06/22/2005 | CN1628787A Method for separating and extracting effective constituent from Sand Ginger by bi-enzyme method |
| 06/22/2005 | CN1628783A Oral liquor containing creeping oxalis, zedoary and dahurian angelica and its preparing method |
| 06/22/2005 | CN1628763A Cassia twig and Tuckahoe formulation for treating gynecological disease and its preparation process |
| 06/22/2005 | CN1628738A 'Shengmai' injection and its preparation process |
| 06/22/2005 | CN1628721A Medicine for treating mammary cancer recurrence and metastasis and the preparation thereof |
| 06/22/2005 | CN1628719A Chinese traditional medicine for treating various malignant tumors |
| 06/22/2005 | CN1628709A Method for preparing lung benefiting and obstruction dispersing liquor |
| 06/22/2005 | CN1628693A Glossy ganoderma preparation containing main active substance of glossy ganoderma herb and preparing method thereof |
| 06/22/2005 | CN1628686A Radix salviae miltiorrhizae oligosaccharide and its application for resisting acquired immunodeficiency syndrome, adjusting immunity and increasing leukocyte |
| 06/22/2005 | CN1628677A Fat Emulsion transfusion liquid for preventing and curing tumour and production method thereof |
| 06/22/2005 | CN1628676A Microcapsule for preventing and curing tumour and production method thereof |
| 06/22/2005 | CN1628652A Method for treating palmar fascia and plantar aponeurosis fibromatosis |
| 06/22/2005 | CN1628638A Liposome preparation containing Oxaliplatin |
| 06/22/2005 | CN1207323C Bivalent reaction water-soluble high molecular derivative and complex including the same |
| 06/22/2005 | CN1207305C Preparing process and application of recombinant human interleukin-11 |
| 06/22/2005 | CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents |
| 06/22/2005 | CN1207296C Farnesyl transferase inhibiting 1, 2-annelated quinoline enantiomer |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207283C 4-aminopiperidine derivatives and their use as medicine |
| 06/22/2005 | CN1207034C Chinese medicinal honey bolus for treating various cancer |
| 06/22/2005 | CN1207030C Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity |